224 related articles for article (PubMed ID: 34954129)
1. Specific Regulation of m
Cun Y; An S; Zheng H; Lan J; Chen W; Luo W; Yao C; Li X; Huang X; Sun X; Wu Z; Hu Y; Li Z; Zhang S; Wu G; Yang M; Tang M; Yu R; Liao X; Gao G; Zhao W; Wang J; Li J
Genomics Proteomics Bioinformatics; 2023 Aug; 21(4):707-728. PubMed ID: 34954129
[TBL] [Abstract][Full Text] [Related]
2. microRNAs target SRSF7 splicing factor to modulate the expression of osteopontin splice variants in renal cancer cells.
Boguslawska J; Sokol E; Rybicka B; Czubaty A; Rodzik K; Piekielko-Witkowska A
Gene; 2016 Dec; 595(2):142-149. PubMed ID: 27664584
[TBL] [Abstract][Full Text] [Related]
3. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
4. SRSF7 maintains its homeostasis through the expression of Split-ORFs and nuclear body assembly.
Königs V; de Oliveira Freitas Machado C; Arnold B; Blümel N; Solovyeva A; Löbbert S; Schafranek M; Ruiz De Los Mozos I; Wittig I; McNicoll F; Schulz MH; Müller-McNicoll M
Nat Struct Mol Biol; 2020 Mar; 27(3):260-273. PubMed ID: 32123389
[TBL] [Abstract][Full Text] [Related]
5. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
[No Abstract] [Full Text] [Related]
6. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
7. Serine/arginine-rich splicing factor 7 regulates p21-dependent growth arrest in colon cancer cells.
Saijo S; Kuwano Y; Masuda K; Nishikawa T; Rokutan K; Nishida K
J Med Invest; 2016; 63(3-4):219-26. PubMed ID: 27644562
[TBL] [Abstract][Full Text] [Related]
8. SRSF3 and SRSF7 modulate 3'UTR length through suppression or activation of proximal polyadenylation sites and regulation of CFIm levels.
Schwich OD; Blümel N; Keller M; Wegener M; Setty ST; Brunstein ME; Poser I; Mozos IRL; Suess B; Münch C; McNicoll F; Zarnack K; Müller-McNicoll M
Genome Biol; 2021 Mar; 22(1):82. PubMed ID: 33706811
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
10. Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma.
Correa BR; de Araujo PR; Qiao M; Burns SC; Chen C; Schlegel R; Agarwal S; Galante PA; Penalva LO
Genome Biol; 2016 Jun; 17(1):125. PubMed ID: 27287018
[TBL] [Abstract][Full Text] [Related]
11. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
12. SRSF7 is a promising prognostic biomarker in hepatocellular carcinoma and is associated with immune infiltration.
Shen W; Yuan L; Cheng F; Wu Z; Li X
Genes Genomics; 2024 Jan; 46(1):49-64. PubMed ID: 37985547
[TBL] [Abstract][Full Text] [Related]
13. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
[TBL] [Abstract][Full Text] [Related]
14. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
[TBL] [Abstract][Full Text] [Related]
15. N
Li F; Yi Y; Miao Y; Long W; Long T; Chen S; Cheng W; Zou C; Zheng Y; Wu X; Ding J; Zhu K; Chen D; Xu Q; Wang J; Liu Q; Zhi F; Ren J; Cao Q; Zhao W
Cancer Res; 2019 Nov; 79(22):5785-5798. PubMed ID: 31530567
[TBL] [Abstract][Full Text] [Related]
16. SRSF7 knockdown promotes apoptosis of colon and lung cancer cells.
Fu Y; Wang Y
Oncol Lett; 2018 Apr; 15(4):5545-5552. PubMed ID: 29556298
[TBL] [Abstract][Full Text] [Related]
17. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation.
Carlson SM; Soulette CM; Yang Z; Elias JE; Brooks AN; Gozani O
J Biol Chem; 2017 Aug; 292(32):13381-13390. PubMed ID: 28655759
[TBL] [Abstract][Full Text] [Related]
18. Circ_0006006 facilitates non-small cell lung cancer progression by modulating miR-924/SRSF7 axis.
Xu Q; Shi J; Zhang L; Sheng Y; Zhang Y; Chu D; Xu A
J Gene Med; 2022 May; 24(5):e3411. PubMed ID: 35037349
[TBL] [Abstract][Full Text] [Related]
19. Serine/Arginine-Rich Splicing Factor 7 Knockdown Inhibits Aerobic Glycolysis and Growth in HepG2 Cells by Regulating PKM2 Expression.
Shi W; Yao X; Cao X; Fu Y; Wang Y
Curr Issues Mol Biol; 2024 May; 46(5):5023-5036. PubMed ID: 38785569
[TBL] [Abstract][Full Text] [Related]
20. Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development.
Tang SJ; Shen H; An O; Hong H; Li J; Song Y; Han J; Tay DJT; Ng VHE; Bellido Molias F; Leong KW; Pitcheshwar P; Yang H; Chen L
Nat Commun; 2020 Feb; 11(1):799. PubMed ID: 32034135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
